(a) Categorical variables
| Variable | PC (%) | NSCLC (%) |
|---|---|---|
| Gender | ||
| Men | 53.0% | 63.4% |
| Women | 47.0% | 36.6% |
| Radiotherapy | 13.4% | 69.0% |
| Chemotherapy | 73.3% | 76.0% |
| Surgery | 40.1% | 10.0% |
| Stage | ||
| Stage 1 | 11.3% | |
| Stage 2 | 7.0% | |
| Stage 3 | 21.1% | |
| Stage 4 | 60.6% |
(a) Categorical variables
| Variable | PC (%) | NSCLC (%) |
|---|---|---|
| Gender | ||
| Men | 53.0% | 63.4% |
| Women | 47.0% | 36.6% |
| Radiotherapy | 13.4% | 69.0% |
| Chemotherapy | 73.3% | 76.0% |
| Surgery | 40.1% | 10.0% |
| Stage | ||
| Stage 1 | 11.3% | |
| Stage 2 | 7.0% | |
| Stage 3 | 21.1% | |
| Stage 4 | 60.6% |